Convergence of the tuberculosis and diabetes epidemics: Renewal of old acquaintances

Clinical Infectious Diseases

Volumn 45, Issue 4, 2007, Pages 436-438

  Restrepo, Blanca I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; COMORBIDITY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIC; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INFECTION RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREVALENCE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; HUMANS; PREVALENCE; TUBERCULOSIS, PULMONARY;

EID: 34547631077     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/519939     Document Type: Note

References (29)

1. Centers for Disease Control and Prevention. Diabetes: disabling, deadly and on the rise. 2002. Available at: http.//wwwcdcgov/diabetes/pubs/ glance.htm. Accessed 5 May 2007.
2. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35:93-9.
3. Tuberculosis fact sheet (revision, March 2004). Wkly Epidemiol Rec 2004; 79:125-8.
4. Ruder K. Fighting the epidemic: a United Nations resolution on diabetes. Diabetes Forecast 2007; 60:50-1.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-53.
6. World Health Organization (WHO). WHO report 2007. Global tuberculosis control: surveillance, planning, financing. Available at: http://wwwwhoint/tb/ publications/global_report/2007/pdf/full.pdf. Accessed 5 May 2007.
7. Oscarsson N, Silwer H. Incidence of pulmonary tuberculosis among diabetics. Acta Med Scand 1958; 160 (Suppl 335):23-48.
8. Root HF. The association of diabetes and tuberculosis. N Engl J Med 1934; 210:1-13.
9. Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R. Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 1952; 65:1-50.
10. Banyai AL. Diabetes and pulmonary tuberculosis. Am Rev Tuberc 1931; 24:650-67.
11. Bacakoglu F, Basoglu OO, Cok G, Sayiner A, Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001; 68: 595-600.
12. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001; 120: 1514-9.
13. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002; 34:752-9.
14. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87:574-9.
15. Perez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Vargas MH. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000; 162:1738-40.
16. Perez A, Brown HS III, Restrepo BI. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg 2006; 74:604-11.
17. Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007; 135:483-91.
18. Alisjahbana B, van Crevel R, Sahiratmadja E, et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006; 10:696-700.
19. Nijland HM, Ruslami R, Stalenhoef JE, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 2006; 43:848-54.
20. Balde NM, Camara A, Camara LM, Diallo MM, Kake A, Bah-Sow OY. Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis 2006; 10:1036-40.
21. Hill PC, Jackson-Sillah D, Donkor SA, Otu J, Adegbola RA, Lienhardt C. Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health 2006; 6:156.
22. Coker R, McKee M, Atun R, et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2006; 332:85-7.
23. Ponce-De-Leon A, Garcia-Garcia Md ML, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004; 27:1584-90.
24. Shetty N, Shemko M, Vaz M, D'Souza G. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis 2006; 10: 80-6.
25. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49(RR-6):1-51.
26. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
27. Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006; 10:74-9.
28. Guler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007; 61:231-5.
29. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes on presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45:428-35 (in this issue).